RecallRadar

FDA Device recall Z-2253-2013

GE Healthcare Discovery IGS 730 Cardiovascular X-Ray Imaging System

On 2013-09-25 the FDA classified a Class II recall of GE Healthcare Discovery IGS 730 Cardiovascular X-Ray Imaging System by Ge Healthcare, citing GE Healthcare has recently become aware of a potential safety issue with respect to Discovery IGS 730 Imaging Systems. A patient data management error may prevent the Discovery IG….

Read the official FDA Device notice

AgencyFDA Device
Recall numberZ-2253-2013
ClassificationClass II
Statusterminated
Initiated2013-06-19
Published2013-09-25
Last updated2026-09-13 11:53 UTC
CompanyGe Healthcare
DistributionUS

Product

GE Healthcare Discovery IGS 730 Cardiovascular X-Ray Imaging System. The angiography X-ray systems are indicated for use in generating fluoroscopic and rotational images of human anatomy for cardiovascular, vascular and non-vascular, diagnostic and interventional procedures. Additionally, with the OR table, the angiographic X-ray systems are indicated for use in generating fluoroscopic and rotational images of human anatomy for image guided surgical procedures. The OR table is suitable for interventional and surgical procedures.

Reason

GE Healthcare has recently become aware of a potential safety issue with respect to Discovery IGS 730 Imaging Systems. A patient data management error may prevent the Discovery IGS 730 Imaging System from booting on start-up or re-booting during procedure. The boot issue may occur when a large amount of patient data remains in the browser and is not deleted. The inability to boot the system ma

Identifiers

code_infoMfg Lot or Serial # 00000611882BU2 00000612803BU7 00000613979BU4 00000620447BU3

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:53 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-2253-2013%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.